InflaRx N.V. cash flow statement IFRX
Annual
Quarterly
No matching figures were found for this statement.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IFRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Jena, Germany
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1708688
- Former names
- Fireman B.V. (until Nov 8, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.